VANCOUVER, BRITISH COLUMBIA --
- Revenue of $39.4 Million, increase of 22% from Q3 2013
- Gross Sending Volume of $1.7 Billion, increase of 13% from Q3 2013
- 1,221,733 Active Customers, increase of 22% from Q3 2013
- CFO Ryno Blignaut stepping down; will be succeeded by VP of Finance Matt Hibbard
SAN FRANCISCO, Oct.
Zillow Data Dashboard offers single-sign on technology, robust reporting and faster processing; Intermountain MLS in Idaho is first to implement Dashboard, followed by MLSs in Oklahoma, Nevada and Florida
SEATTLE , Jan.
By Jennifer Booton, MarketWatch NBC's "Peter Pan" pulls in half the viewers of "The Sound of Music"
NEW YORK (MarketWatch)--NBC may have high hopes for live theater in the future of broadcast television, but a flop of its live rendition of "Peter Pan" Thursday night might change its mind.
PLEASANTON, CA --
By Claudia Assis, MarketWatch
SAN FRANCISCO (MarketWatch) -- Prices for residential solar-power systems are expected to drop 3% to 12% this year, continuing a trend that has seen prices fall by double digits in the last couple of years, according to a report released Tuesday.
Renewable Energy Group, Inc. (NASDAQ: REGI) announced today a
partnership between its blended fuels division and CyRide, the transit
agency serving the City of Ames and Iowa State University, to supply
biodiesel blended fuel in 2015 for its CyRide bus fleet.
Veeva Systems, a leading provider of industry cloud solutions for life
sciences, today announced it has been honored by several prestigious
industry awards, recognizing it as one of the fastest growing, most
innovative leaders in cloud technology.
Puma Biotechnology, Inc. (NYSE: PBYI), a development stage
biopharmaceutical company, announced that interim results from an
ongoing Phase II clinical trial of Puma's investigational drug PB272
(neratinib) were presented at the 2014 CTRC-AACR San Antonio Breast
Cancer Symposium (SABCS) that is currently taking place in San Antonio,
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.